92 related articles for article (PubMed ID: 21917878)
1. Influenza B virus with modified hemagglutinin cleavage site as a novel attenuated live vaccine.
Stech J; Garn H; Herwig A; Stech O; Dauber B; Wolff T; Mettenleiter TC; Klenk HD
J Infect Dis; 2011 Nov; 204(10):1483-90. PubMed ID: 21917878
[TBL] [Abstract][Full Text] [Related]
2. The potential of a protease activation mutant of a highly pathogenic avian influenza virus for a pandemic live vaccine.
Gabriel G; Garn H; Wegmann M; Renz H; Herwig A; Klenk HD; Stech J
Vaccine; 2008 Feb; 26(7):956-65. PubMed ID: 18164519
[TBL] [Abstract][Full Text] [Related]
3. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.
Pavlova SP; Veits J; Keil GM; Mettenleiter TC; Fuchs W
Vaccine; 2009 Jan; 27(5):773-85. PubMed ID: 19041677
[TBL] [Abstract][Full Text] [Related]
4. A new approach to an influenza live vaccine: modification of the cleavage site of hemagglutinin.
Stech J; Garn H; Wegmann M; Wagner R; Klenk HD
Nat Med; 2005 Jun; 11(6):683-9. PubMed ID: 15924146
[TBL] [Abstract][Full Text] [Related]
5. Development and characterization of a live attenuated influenza B virus vaccine candidate.
Seo SU; Byun YH; Lee EY; Jung EJ; Jang YH; Kim HA; Ha SH; Lee KH; Seong BL
Vaccine; 2008 Feb; 26(7):874-81. PubMed ID: 18207290
[TBL] [Abstract][Full Text] [Related]
6. A new approach to an influenza life vaccine: haemagglutinin cleavage site mutants generated by reverse genetics.
Stech J; Klenk HD
Berl Munch Tierarztl Wochenschr; 2006; 119(3-4):186-91. PubMed ID: 16573209
[TBL] [Abstract][Full Text] [Related]
7. Attenuated influenza A viruses with modified cleavage sites in hemagglutinin as live vaccines.
Stech J
Expert Rev Vaccines; 2008 Aug; 7(6):739-43. PubMed ID: 18665773
[TBL] [Abstract][Full Text] [Related]
8. A protective immune response in mice to viral components other than hemagglutinin in a live influenza A virus vaccine model.
Horimoto T; Takada A; Iwatsuki-Horimoto K; Kawaoka Y
Vaccine; 2004 Jun; 22(17-18):2244-7. PubMed ID: 15149783
[TBL] [Abstract][Full Text] [Related]
9. Development of a live-attenuated influenza B DeltaNS1 intranasal vaccine candidate.
Wressnigg N; Voss D; Wolff T; Romanova J; Ruthsatz T; Mayerhofer I; Reiter M; Nakowitsch S; Humer J; Morokutti A; Muster T; Egorov A; Kittel C
Vaccine; 2009 May; 27(21):2851-7. PubMed ID: 19366569
[TBL] [Abstract][Full Text] [Related]
10. Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus.
Lee KH; Seo SU; Song JM; Lee CM; Kim HA; Seong BL
Vaccine; 2006 Mar; 24(11):1966-74. PubMed ID: 16343703
[TBL] [Abstract][Full Text] [Related]
11. A live bivalent influenza vaccine based on a H9N2 virus strain.
Wu R; Guan Y; Yang Z; Chen J; Wang H; Chen Q; Sui Z; Fang F; Chen Z
Vaccine; 2010 Jan; 28(3):673-80. PubMed ID: 19892041
[TBL] [Abstract][Full Text] [Related]
12. Universal influenza B vaccine based on the maturational cleavage site of the hemagglutinin precursor.
Bianchi E; Liang X; Ingallinella P; Finotto M; Chastain MA; Fan J; Fu TM; Song HC; Horton MS; Freed DC; Manger W; Wen E; Shi L; Ionescu R; Price C; Wenger M; Emini EA; Cortese R; Ciliberto G; Shiver JW; Pessi A
J Virol; 2005 Jun; 79(12):7380-8. PubMed ID: 15919893
[TBL] [Abstract][Full Text] [Related]
13. Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential.
Desheva JA; Lu XH; Rekstin AR; Rudenko LG; Swayne DE; Cox NJ; Katz JM; Klimov AI
Vaccine; 2006 Nov; 24(47-48):6859-66. PubMed ID: 17050041
[TBL] [Abstract][Full Text] [Related]
14. [Genome composition analysis of the reassortant influenza viruses used in seasonal and pandemic live attenuated influenza vaccine].
Kiseleva IV; Voeten JT; Teley LC; Larionova NV; Dubrovina IA; Berdygulova ZhA; Bazhenova EA; van den Bosch H; Heldens JG; Rudenko LG
Mol Gen Mikrobiol Virusol; 2011; (4):29-36. PubMed ID: 22312898
[TBL] [Abstract][Full Text] [Related]
15. Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain.
de Wit E; Munster VJ; Spronken MI; Bestebroer TM; Baas C; Beyer WE; Rimmelzwaan GF; Osterhaus AD; Fouchier RA
J Virol; 2005 Oct; 79(19):12401-7. PubMed ID: 16160167
[TBL] [Abstract][Full Text] [Related]
16. Development of live attenuated Bordetella pertussis strains expressing the universal influenza vaccine candidate M2e.
Li R; Lim A; Ow ST; Phoon MC; Locht C; Chow VT; Alonso S
Vaccine; 2011 Jul; 29(33):5502-11. PubMed ID: 21624415
[TBL] [Abstract][Full Text] [Related]
17. Immediate and broad-spectrum protection against heterologous and heterotypic lethal challenge in mice by live influenza vaccine.
Seo SU; Lee KH; Byun YH; Kweon MN; Seong BL
Vaccine; 2007 Nov; 25(47):8067-76. PubMed ID: 17919786
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity.
Belshe RB; Coelingh K; Ambrose CS; Woo JC; Wu X
Vaccine; 2010 Feb; 28(9):2149-56. PubMed ID: 20003926
[TBL] [Abstract][Full Text] [Related]
19. Influenza virus-like particle can accommodate multiple subtypes of hemagglutinin and protect from multiple influenza types and subtypes.
Pushko P; Pearce MB; Ahmad A; Tretyakova I; Smith G; Belser JA; Tumpey TM
Vaccine; 2011 Aug; 29(35):5911-8. PubMed ID: 21723354
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and protective efficacy of an elastase-dependent live attenuated swine influenza virus vaccine administered intranasally in pigs.
Masic A; Lu X; Li J; Mutwiri GK; Babiuk LA; Brown EG; Zhou Y
Vaccine; 2010 Oct; 28(43):7098-108. PubMed ID: 20708697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
